Varicose veins are a prevalent venous disorder, often resulting in symptoms like aching, swelling, and skin
changes, and can significantly impact a patient’s quality of life. With the evolution of minimally invasive
treatments, vascular surgeons now have an array of non-surgical options that provide effective outcomes with
fewer complications and shorter recovery times compared to traditional vein stripping. This detailed review
explores the latest advancements in non-surgical treatments, offering insights into their mechanisms,
indications, benefits, and limitations for clinical practice.
Endovenous Laser Ablation (EVLA)
Mechanism : Endovenous laser ablation (EVLA) uses ultrasound guidance to insert a laser fiber into
the saphenous vein. The laser emits thermal energy, causing vein wall contraction and eventual fibrosis.
Indications :
- Great saphenous vein (GSV) incompetence
- Small saphenous vein (SSV) incompetence
- Perforator veins
Procedure Details :
- Performed under tumescent anesthesia
- Laser wavelengths (810, 940, 980, 1470 nm) with radial fibers offer improved outcomes
- Energy settings range between 60-100 J/cm
Benefits :
- High occlusion rates (95%-98%)
- Outpatient procedure with minimal downtime
- Reduced postoperative pain with modern wavelength lasers
Limitations :
- Risk of thermal injury to surrounding tissues
- Potential for recanalization in some cases
- Superficial phlebitis
Radiofrequency Ablation (RFA)
Mechanism : RFA involves the delivery of radiofrequency energy through a catheter, generating heat
(120°C) that leads to collagen contraction and vein closure. Catheters like the ClosureFAST system ensure
even heating.
Indications :
- Incompetent saphenous veins
- Perforator vein incompetence
Procedure Details :
- Tumescent anesthesia used to create a thermal barrier and compress the vein
- Segmental ablation allows uniform heat application over 20-second cycles
Benefits :
- Comparable efficacy to EVLA with less postoperative pain
- Higher patient satisfaction due to minimal bruising and quicker return to activities
- Success rates over 95% at three years
Limitations :
- Requires more significant capital investment for the RFA generator
- Vein diameter may limit effectiveness; larger veins may need adjunct treatments
Ultrasound-Guided Foam Sclerotherapy (UGFS)
Mechanism : UGFS uses a sclerosant foam (polidocanol or sodium tetradecyl sulfate) injected into the
vein under ultrasound guidance, causing endothelial damage, inflammation, and subsequent vein obliteration.
Indications :
- Residual varicose veins post-EVLA/RFA
- Recurrent varicose veins
- Patients unsuitable for thermal ablation
Procedure Details :
- Foam preparation using the Tessari or double-syringe technique
- Concentration of sclerosant (0.5%-3%) based on vein size and location
Benefits :
- Can treat tortuous veins not amenable to straight catheter-based techniques
- Performed in an outpatient setting without anesthesia
- Minimal equipment requirements
Limitations :
- Higher recurrence rates compared to thermal ablation
- Risk of visual disturbances, transient ischemic attacks (TIAs) in susceptible individuals
- Requires repeat sessions for complete vein closure
Venaseal Closure System
Mechanism : The Venaseal system delivers a cyanoacrylate adhesive into the vein lumen, leading to
immediate closure via polymerization and adhesion of the vein walls.
Indications :
- Saphenous vein incompetence
- Patients contraindicated for tumescent anesthesia
Procedure Details :
- Performed without tumescent anesthesia or post-procedure compression stockings
- The adhesive is delivered via a catheter, guided by ultrasound
Benefits :
- Immediate vein closure without heat or sclerosant
- No need for tumescent anesthesia reduces procedure time
- Reduced post-operative pain and no need for compression stockings
Limitations :
- Potential for phlebitis at the treatment site
- Limited long-term data compared to EVLA and RFA
- Higher initial cost of the adhesive material
Mechanochemical Ablation (MOCA)
Mechanism: MOCA combines mechanical disruption of the vein endothelium with simultaneous
administration of a sclerosant. Devices like the ClariVein system use a rotating catheter tip for mechanical
injury.
Indications:
- Great and small saphenous vein incompetence
- Patients desiring a non-thermal, non-tumescent option
Procedure Details :
- Sclerosant (e.g., polidocanol) is infused while the rotating catheter disrupts the endothelium
- No need for tumescent anesthesia
Benefits :
- No thermal injury risk
- Minimal pain and bruising
- Rapid recovery and high patient satisfaction
Limitations :
- Limited to veins up to 12 mm in diameter
- Lack of long-term efficacy data compared to thermal ablation
- Requires specific equipment and training
Clinical Decision-Making and Patient Selection
The choice of treatment depends on several factors, including vein anatomy, patient comorbidities,
preferences, and available resources. Comprehensive duplex ultrasound evaluation is essential for mapping
venous insufficiency and guiding treatment selection. In many cases, combining different modalities (e.g.,
EVLA with UGFS) offers superior outcomes.
Modern non-surgical treatments for varicose veins provide vascular surgeons with effective, patient-centered
approaches to managing venous insufficiency. Each technique has its advantages and limitations, requiring
careful patient selection and procedural expertise. As these technologies continue to evolve, vascular
surgeons must stay abreast of advancements to offer the best care options tailored to individual patient
needs.
